CEO’s spouse sells Johnson & Johnson (JNJ) shares in reported Form 4

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Johnson & Johnson CEO Joaquin Duato reported indirect stock sales by his spouse. On January 26, 2026, the spouse sold 51,218 Johnson & Johnson common shares at a weighted average price of $220.986 per share in multiple trades, and another 48,782 shares at a weighted average price of $221.484 per share.

After these transactions, the filing shows the spouse indirectly holding 79,634 shares and 30,852 shares in two accounts. Joaquin Duato is also shown as directly holding 275,967 common shares and 988 shares through a 401(k) plan as of the plan’s most recent reporting date.

Insider Trade Summary

Net Seller: 100,000 shares ($22,122,893)

Net Sell 4 txns

Insider Duato Joaquin

Role CEO and Chairman of the Board

Sold 100,000 shs ($22.12M)

Type	Security	Shares	Price	Value
Sale	Common Stock	51,218	$220.986	$11.32M
Sale	Common Stock	48,782	$221.484	$10.80M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 79,634 shares (Indirect, By spouse); Common Stock — 275,967 shares (Direct)

Footnotes (1)

This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2025).

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

01/28/2026 - 06:07 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duato Joaquin

(Last)

(First)

(Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK

08933

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO and Chairman of the Board

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/26/2026		S		51,218	D	$220.986⁽¹⁾	79,634	I	By spouse
Common Stock	01/26/2026		S		48,782	D	$221.484⁽²⁾	30,852	I	By spouse
Common Stock								275,967	D
Common Stock								988⁽³⁾	I	By 401k

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

2. This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2025).

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Joaquin Duato	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Johnson & Johnson (JNJ) report for January 26, 2026?

Johnson & Johnson reported that the spouse of CEO Joaquin Duato sold company common stock on January 26, 2026. Two indirect sale transactions were disclosed, each with its own share amount and weighted average sale price across multiple trades.

How many Johnson & Johnson (JNJ) shares did the CEO’s spouse sell?

The filing shows the CEO’s spouse sold 51,218 Johnson & Johnson common shares in one transaction and 48,782 shares in another. Both transactions were reported as indirect ownership, attributed to the spouse rather than directly to Joaquin Duato.

At what prices were the Johnson & Johnson (JNJ) shares sold on January 26, 2026?

The filing reports weighted average sale prices of $220.986 per share for 51,218 shares and $221.484 per share for 48,782 shares. Each transaction was executed in multiple trades within narrow price ranges disclosed in the explanatory footnotes.

How many Johnson & Johnson (JNJ) shares does Joaquin Duato hold after the reported transactions?

After the reported transactions, the Form 4 shows Joaquin Duato directly holding 275,967 Johnson & Johnson common shares. It also lists an additional 988 shares held indirectly through a 401(k) plan stock fund as of the plan’s most recent reporting date.

What indirect Johnson & Johnson (JNJ) holdings by the CEO’s spouse are shown after the sales?

Following the sales, the filing reports the CEO’s spouse indirectly holding 79,634 Johnson & Johnson shares in one line item and 30,852 shares in another. These positions are labeled as indirect ownership "By spouse" in the non-derivative securities table.

Does the Johnson & Johnson (JNJ) Form 4 involve any derivative securities?

No derivative securities are shown as acquired or disposed of in this Form 4 excerpt. The detailed transaction information relates only to Johnson & Johnson common stock, with derivative securities rows left without reported acquisitions or dispositions.